Skip to content
10-K

Annual Report

MediXall Group, Inc.

0001079973-25-000141

← back to feed
Filed
Jan 27, 2025 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Jan 22, 2025 216.67M sh
Shares Diluted FY 2023 · Dec 31, 2023 127.17M sh
Shares Diluted FY 2023 · Dec 31, 2022 116.66M sh
Operating Cash Flow FY 2023 · Dec 31, 2023 −$1.23M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$3.56M
Stockholders Equity FY 2023 · Dec 31, 2023 −$6.52M
Stockholders Equity FY 2023 · Dec 31, 2022 −$3.67M
Stockholders Equity FY 2023 · Dec 31, 2021 −$340.12K
Current Liabilities FY 2023 · Dec 31, 2023 $6.72M
Current Liabilities FY 2023 · Dec 31, 2022 $4.34M
Total Liabilities FY 2023 · Dec 31, 2023 $6.72M
Total Liabilities FY 2023 · Dec 31, 2022 $4.53M
Current Assets FY 2023 · Dec 31, 2023 $14.21K
Current Assets FY 2023 · Dec 31, 2022 $11.5K
Total Assets FY 2023 · Dec 31, 2023 $201.1K
Total Assets FY 2023 · Dec 31, 2022 $862.01K
Eps Diluted FY 2023 · Dec 31, 2023 −$0.04
Eps Diluted FY 2023 · Dec 31, 2022 −$0.06
Eps Basic FY 2023 · Dec 31, 2023 −$0.04
Eps Basic FY 2023 · Dec 31, 2022 −$0.06
Net Income FY 2023 · Dec 31, 2023 −$4.56M
Net Income FY 2023 · Dec 31, 2022 −$6.83M
Gross Profit FY 2023 · Dec 31, 2023 $72.91K
Gross Profit FY 2023 · Dec 31, 2022 $59.27K
Cost Of Revenue FY 2023 · Dec 31, 2023 $236.51K
Cost Of Revenue FY 2023 · Dec 31, 2022 $0
Revenue FY 2023 · Dec 31, 2023 $309.42K
Revenue FY 2023 · Dec 31, 2022 $59.27K